Thoracic Paravertebral Block for Postoperative Pain Management After VATS
NCT ID: NCT06689358
Last Updated: 2024-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2022-11-01
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Three Different Pain Blocks for Subjects Undergoing VATS (Video Assisted Thoracoscopic Surgery) Procedure.
NCT03151434
Continuous Thoracic Paravertebral Analgesia for Video-assisted Thoracoscopic Surgery
NCT02670759
Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery
NCT00542542
Erector Spinae Plane Block for Video-assisted Thoracoscopic Surgery
NCT03628040
Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain
NCT03280017
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Arm 1: General anesthesia with TPVB;
Arm 2: General anesthesia alone (control group).
Primary Outcome: to assess Opioid requirement in the PACU
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Arm 2: General anesthesia alone (control group). Type: No intervention (control) Intervention: No intervention
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
General anesthesia with TPVB
0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space
0.4 ml/kg of 0.5% bupivacaine
0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space
General anesthesia alone (control group).
General anesthesia SOC alone
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
0.4 ml/kg of 0.5% bupivacaine
0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Hussein Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahed Al-Edwan, MD
Role: PRINCIPAL_INVESTIGATOR
KHCC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
King Hussein Cancer Center
Amman, , Jordan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22 KHCC 158
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.